Samsung Becomes Largest Shareholder in US Genomics Firm Element Biosciences
Samsung Electronics has invested $175 million in Element Biosciences' Series E funding round, making it the largest shareholder in the US genomics firm. This strategic investment positions Samsung as a key player in the biotech sector.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)Sources
Samsung becomes largest shareholder of US genomics firm Element
Samsung Electronics said Wednesday it has invested an additional $175 million in US biotechnology company Element Biosciences, becoming the firm's largest shareholder as it seeks to expand into precision medicine and next-generation healthcare technologies. The investment was made through Element's Series E funding round, following Samsung's participation in the company's Series D financing in July 2024. Samsung said the latest investment will strengthen its position in the rapidly growing preci
By The Korea Herald
Read full article →Samsung Electronics invests $175 million in Element Biosciences' Series E funding round
Read full article →Coverage Timeline
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Philippine Police Intensify Crackdown on Scam Hubs
just now
Wall Street Reacts to Tech Fundraising, SpaceX IPO Impacting Other AI Companies
20m ago
Sundar Pichai Delivers Optimistic Stanford Graduation Speech, Avoids AI Discussion
23m ago